The Children’s Tumor Foundation 2023 Annual Report highlights the year’s progress in NF research, awareness, patient support, and the accomplishments of a dedicated NF community.
In the Letter from the CEO, Annette Bakker reflects on CTF’s 45th anniversary year. “We are now in a new era, where our decades of research, drug discovery, and development are ready to become long-expected life-changing treatments for patients. We have over 60 clinical trials in progress, one drug approved, one drug submitted to the FDA, and another drug in Phase 3. Thanks to you, our steadfast donors, the field is more than ready, the science is ready, and the technology is ready. The time is now to reap the rewards of your dedication.”
Thanks to your support, the Children’s Tumor Foundation is accelerating treatments that will improve the lives of millions of people living with neurofibromatosis or schwannomatosis. None of this would be possible without the support of the thousands of CTF donors who ensure that NF research and programs continue. Thank you.
You can view the report online by clicking the image below. If you prefer to download or print the report, the .pdf version is available here.
